开角型青光眼患者视网膜毛细血管密度进行性丢失与视野进展的关联:基于疾病分期
回顾性观察158眼开角型青光眼(OAG),按视野平均偏差(MD)分为早期89眼和中晚期69眼,平均随访2.66年,用OCT血管成像测视盘周围毛细血管密度(cpCD)和OCT测视网膜神经纤维层厚度(cpRNFLT)。结果显示无论分期,视野进展者cpCD年下降率均显著快于未进展者;中晚期仅cpCD下降率与视野进展显著相关,早期cpCD和cpRNFLT下降率均与视野进展显著相关。
要点
- 无论早期或中晚期OAG,视野进展者cpCD年下降率均显著快于未进展者。
- 中晚期OAG中仅cpCD下降率与视野进展显著相关,cpRNFLT下降率无差异。
- 早期OAG中cpCD和cpRNFLT下降率均与视野进展显著相关。
核心结论
- 在OAG眼中,无论青光眼分期,cpCD纵向下降速率均与视野进展显著相关。
研究设计与样本
- 回顾性观察性病例系列,纳入158例OAG患者的158眼,按视野MD(-6 dB)分为早期89眼和中晚期69眼。
- 使用OCT血管成像和OCT纵向测量cpCD和cpRNFLT,平均随访2.66年。
- 以视野进展为参考标准,采用线性混合效应模型评估cpCD和cpRNFLT的纵向变化率,并用逻辑回归分析视野进展的相关因素。
主要发现
- 视野进展者cpCD年变化率:早期-1.25%±1.15%,中晚期-1.61%±1.04%;未进展者:早期0.04%±1.12%,中晚期-0.34%±0.97%,组间差异均有统计学意义(P<.05)。
- 中晚期青光眼中,进展者与未进展者cpRNFLT年变化率(-0.85±1.20 µm/y vs -0.70±1.02 µm/y)无显著差异(P=.396)。
- 多因素逻辑回归显示,中晚期青光眼中较快的cpCD下降速率与视野进展显著相关(OR 0.244,P=.009)。
- 早期青光眼中,较快的cpCD下降速率(OR 0.340,P=.012)和cpRNFLT下降速率(OR 0.155,P=.031)均与视野进展显著相关。
关键数值与推荐
- 青光眼分期依据视野MD,以-6 dB为界分为早期和中晚期。
- 视野进展作为青光眼进展的参考标准。
临床怎么用
- OCT血管成像测量的cpCD纵向下降速率可作为OAG视野进展的监测指标,尤其在中晚期患者中可能比cpRNFLT更敏感。
- 早期OAG患者应同时关注cpCD和cpRNFLT的纵向变化以评估进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the longitudinal changes in circumpapillary capillary density (cpCD) and retinal nerve fiber layer thickness (cpRNFLT) and their association with visual field (VF) progression in open-angle glaucoma (OAG) eyes at different stages of glaucoma. DESIGN: Retrospective, observational case series METHODS: This study enrolled 158 eyes of 158 OAG patients classified into early (89 eyes) and moderate-to-advanced (69 eyes) stage based on VF mean deviation (MD; -6 dB). Serial cpCD and cpRNFLT measurements were performed using optical coherence tomography (OCT) angiography and OCT during a mean follow-up of 2.66 years. The reference standard of glaucoma progression was determined by VF progression. The rates of longitudinal change in cpCD and cpRNFLT were evaluated using linear mixed effects models and compared between progressors and nonprogressors. The factors associated with VF progression, including the rates of longitudinal change in cpCD and cpRNFLT, were assessed using logistic regression analyses. RESULTS: The rate of longitudinal change in cpCD was significantly faster in progressors (-1.25% ± 1.15% per year for early stage and -1.61% ± 1.04% per year for moderate-to-advanced stage) than in nonprogressors (0.04% ± 1.12% per year for early stage and -0.34% ± 0.97% per year for moderate-to-advanced stage) regardless of glaucoma stage (all, P < .05). The rates of longitudinal change in cpRNFLT (-0.85 ± 1.20 µm/y vs -0.70 ± 1.02 µm/y, P = .396) did not differ between progressors and nonprogressors in eyes with moderate-to-advanced glaucoma. In multivariable logistic regression analyses, a faster rate of cpCD loss (odds ratio [OR] 0.244, P = .009) had a significant association with VF progression in eyes with moderate-to-advanced glaucoma, whereas faster rates of both cpCD (OR 0.340, P = .012) and cpRNFLT (OR 0.155, P = .031) loss were significantly associated with VF progression in eyes with early-stage glaucoma. CONCLUSIONS: In OAG eyes, the rate of longitudinal cpCD loss was significantly associated with VF progression regardless of glaucoma stage.
引用
- Shin JW, Song MK, Kook MS, et al. Association Between Progressive Retinal Capillary Density Loss and Visual Field Progression in Open-Angle Glaucoma Patients According to Disease Stage. Am J Ophthalmol. 2021. PMID: 33524366. doi:10.1016/j.ajo.2021.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。